Home/Filings/4/0000899243-22-007520
4//SEC Filing

Dornan David 4

Accession 0000899243-22-007520

CIK 0001641281other

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 9:19 PM ET

Size

5.6 KB

Accession

0000899243-22-007520

Insider Transaction Report

Form 4
Period: 2022-02-18
Dornan David
Chief Scientific Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-02-18+210,000210,000 total
    Exercise: $3.08Exp: 2032-02-17Common Stock (210,000 underlying)
Footnotes (1)
  • [F1]For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2022.

Issuer

Bolt Biotherapeutics, Inc.

CIK 0001641281

Entity typeother

Related Parties

1
  • filerCIK 0001821353

Filing Metadata

Form type
4
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 9:19 PM ET
Size
5.6 KB